tadalafil
Generic: tadalafil
Labeler: amneal pharmaceuticals ny llcDrug Facts
Product Profile
Brand Name
tadalafil
Generic Name
tadalafil
Labeler
amneal pharmaceuticals ny llc
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
tadalafil 2.5 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
60219-1346
Product ID
60219-1346_826351a8-9666-447a-beca-40027a773f2b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA209744
Listing Expiration
2026-12-31
Marketing Start
2019-03-27
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
602191346
Hyphenated Format
60219-1346
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
tadalafil (source: ndc)
Generic Name
tadalafil (source: ndc)
Application Number
ANDA209744 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2.5 mg/1
Packaging
- 30 TABLET, FILM COATED in 1 BOTTLE (60219-1346-3)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "826351a8-9666-447a-beca-40027a773f2b", "openfda": {"nui": ["N0000175599", "N0000020026"], "unii": ["742SXX0ICT"], "rxcui": ["402019", "403957", "484814", "757707"], "spl_set_id": ["2cad2167-dbd1-4df8-b407-b270487d027b"], "pharm_class_epc": ["Phosphodiesterase 5 Inhibitor [EPC]"], "pharm_class_moa": ["Phosphodiesterase 5 Inhibitors [MoA]"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (60219-1346-3)", "package_ndc": "60219-1346-3", "marketing_start_date": "20190327"}], "brand_name": "Tadalafil", "product_id": "60219-1346_826351a8-9666-447a-beca-40027a773f2b", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Phosphodiesterase 5 Inhibitor [EPC]", "Phosphodiesterase 5 Inhibitors [MoA]"], "product_ndc": "60219-1346", "generic_name": "Tadalafil", "labeler_name": "Amneal Pharmaceuticals NY LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tadalafil", "active_ingredients": [{"name": "TADALAFIL", "strength": "2.5 mg/1"}], "application_number": "ANDA209744", "marketing_category": "ANDA", "marketing_start_date": "20190327", "listing_expiration_date": "20261231"}